Viatris Inc. Common Stock (VTRS)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of Viatris Inc. Common Stock (VTRS)
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
Key Insights
Critical company metrics and information
Share Price
$12.54Market Cap
$14.97 BillionTotal Outstanding Shares
1.19 Billion SharesTotal Employees
38,000Dividend
$0.12 Per Share QuarterlyIPO Date
April 14, 1986SIC Description
Pharmaceutical PreparationsHomepage
https://www.viatris.com
Historical Stock Splits
Execution Date | Split Amount |
---|---|
No Historical Stock Splits |
Cash Flow Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow | $961.60 Million |
Exchange Gains/Losses | $23.90 Million |
Net Cash Flow From Investing Activities, Continuing | $1.75 Billion |
Net Cash Flow From Investing Activities | $1.75 Billion |
Net Cash Flow, Continuing | $937.70 Million |
Net Cash Flow From Operating Activities, Continuing | $826.50 Million |
Net Cash Flow From Financing Activities, Continuing | $-1.64 Billion |
Net Cash Flow From Operating Activities | $826.50 Million |
Net Cash Flow From Financing Activities | $-1.64 Billion |
Income Statement
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Income/Loss From Continuing Operations After Tax | $94.80 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Basic Average Shares | $1.19 Billion |
Income/Loss From Continuing Operations Before Tax | $90.50 Million |
Net Income/Loss Attributable To Parent | $94.80 Million |
Common Stock Dividends | $0.12 |
Other Operating Expenses | $31.50 Million |
Diluted Earnings Per Share | $0.08 |
Basic Earnings Per Share | $0.08 |
Diluted Average Shares | $1.20 Billion |
Income Tax Expense/Benefit, Deferred | $-312.40 Million |
Costs And Expenses | $3.66 Billion |
Interest Expense, Operating | $145.60 Million |
Net Income/Loss Available To Common Stockholders, Basic | $94.80 Million |
Selling, General, and Administrative Expenses | $1.00 Billion |
Gross Profit | $1.46 Billion |
Cost Of Revenue | $2.29 Billion |
Net Income/Loss | $94.80 Million |
Operating Income/Loss | $225.90 Million |
Income Tax Expense/Benefit | $-4.30 Million |
Operating Expenses | $1.23 Billion |
Benefits Costs and Expenses | $3.66 Billion |
Revenues | $3.75 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Research and Development | $198.40 Million |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Balance Sheet
July 1, 2024 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $24.96 Billion |
Liabilities And Equity | $44.75 Billion |
Prepaid Expenses | $134.50 Million |
Current Assets | $11.31 Billion |
Noncurrent Liabilities | $17.45 Billion |
Equity Attributable To Parent | $19.79 Billion |
Other Current Assets | $4.23 Billion |
Assets | $44.75 Billion |
Wages | $668.20 Million |
Equity | $19.79 Billion |
Noncurrent Assets | $33.45 Billion |
Other Non-current Assets | $12.79 Billion |
Intangible Assets | $17.98 Billion |
Fixed Assets | $2.68 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Other Current Liabilities | $6.84 Billion |
Inventory | $4.08 Billion |
Accounts Receivable | $2.86 Billion |
Current Liabilities | $7.51 Billion |
Historical Dividends
Current dividend: $0.12 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Nov 4, 2024 | Dec 13, 2024 | Nov 22, 2024 | $0.12 | Quarterly |
Aug 5, 2024 | Sep 13, 2024 | Aug 23, 2024 | $0.12 | Quarterly |
May 6, 2024 | Jun 14, 2024 | May 24, 2024 | $0.12 | Quarterly |
Feb 26, 2024 | Mar 18, 2024 | Mar 11, 2024 | $0.12 | Quarterly |
Nov 7, 2023 | Dec 15, 2023 | Nov 24, 2023 | $0.12 | Quarterly |
Aug 4, 2023 | Sep 15, 2023 | Aug 24, 2023 | $0.12 | Quarterly |
May 5, 2023 | Jun 16, 2023 | May 24, 2023 | $0.12 | Quarterly |
Feb 24, 2023 | Mar 17, 2023 | Mar 9, 2023 | $0.12 | Quarterly |
Nov 7, 2022 | Dec 16, 2022 | Nov 23, 2022 | $0.12 | Quarterly |
Aug 4, 2022 | Sep 16, 2022 | Aug 24, 2022 | $0.12 | Quarterly |
May 5, 2022 | Jun 16, 2022 | May 24, 2022 | $0.12 | Quarterly |
Jan 6, 2022 | Mar 16, 2022 | Feb 24, 2022 | $0.12 | Quarterly |
Nov 8, 2021 | Dec 16, 2021 | Nov 23, 2021 | $0.11 | Quarterly |
Aug 9, 2021 | Sep 16, 2021 | Aug 24, 2021 | $0.11 | Quarterly |
May 10, 2021 | Jun 16, 2021 | May 24, 2021 | $0.11 | Quarterly |
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.